Clinical Trial Update: Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions [NA]

View source ↗

Summary

Clinical trial update comparing repaglinide and metformin on glucose excursions in type 2 diabetes; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)
• metformin (metformin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN